This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4qe6
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==FXR with CDCA and NCoA-2 peptide== | ==FXR with CDCA and NCoA-2 peptide== | ||
| - | <StructureSection load='4qe6' size='340' side='right' caption='[[4qe6]], [[Resolution|resolution]] 1.65Å' scene=''> | + | <StructureSection load='4qe6' size='340' side='right'caption='[[4qe6]], [[Resolution|resolution]] 1.65Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4qe6]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4qe6]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QE6 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4QE6 FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=JN3:CHENODEOXYCHOLIC+ACID'>JN3</scene> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=JN3:CHENODEOXYCHOLIC+ACID'>JN3</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4qe6 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qe6 OCA], [https://pdbe.org/4qe6 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4qe6 RCSB], [https://www.ebi.ac.uk/pdbsum/4qe6 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4qe6 ProSAT]</span></td></tr> | |
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
| - | == Disease == | ||
| - | [[http://www.uniprot.org/uniprot/NCOA2_HUMAN NCOA2_HUMAN]] Note=Chromosomal aberrations involving NCOA2 may be a cause of acute myeloid leukemias. Inversion inv(8)(p11;q13) generates the KAT6A-NCOA2 oncogene, which consists of the N-terminal part of KAT6A and the C-terminal part of NCOA2/TIF2. KAT6A-NCOA2 binds to CREBBP and disrupts its function in transcription activation. | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/NR1H4_HUMAN NR1H4_HUMAN] Ligand-activated transcription factor. Receptor for bile acids such as chenodeoxycholic acid, lithocholic acid and deoxycholic acid. Represses the transcription of the cholesterol 7-alpha-hydroxylase gene (CYP7A1) through the induction of NR0B2 or FGF19 expression, via two distinct mechanisms. Activates the intestinal bile acid-binding protein (IBABP). Activates the transcription of bile salt export pump ABCB11 by directly recruiting histone methyltransferase CARM1 to this locus.<ref>PMID:10334992</ref> <ref>PMID:10334993</ref> <ref>PMID:12815072</ref> <ref>PMID:15471871</ref> <ref>PMID:12718892</ref> <ref>PMID:18621523</ref> <ref>PMID:19410460</ref> <ref>PMID:19586769</ref> |
| + | |||
| + | ==See Also== | ||
| + | *[[Bile acid receptor 3D structures|Bile acid receptor 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: Bamberg | + | [[Category: Large Structures]] |
| - | [[Category: Dekker | + | [[Category: Bamberg K]] |
| - | [[Category: Kudlinzki | + | [[Category: Dekker N]] |
| - | [[Category: Linhard | + | [[Category: Kudlinzki D]] |
| - | [[Category: Merk | + | [[Category: Linhard VL]] |
| - | [[Category: Nilsson | + | [[Category: Merk D]] |
| - | [[Category: Saxena | + | [[Category: Nilsson E]] |
| - | [[Category: Schubert-Zsilavecz | + | [[Category: Saxena K]] |
| - | [[Category: Schwalbe | + | [[Category: Schubert-Zsilavecz M]] |
| - | [[Category: Sreeramulu | + | [[Category: Schwalbe H]] |
| - | [[Category: Wissler | + | [[Category: Sreeramulu S]] |
| - | + | [[Category: Wissler L]] | |
| - | + | ||
| - | + | ||
Revision as of 11:25, 15 February 2023
FXR with CDCA and NCoA-2 peptide
| |||||||||||
Categories: Homo sapiens | Large Structures | Bamberg K | Dekker N | Kudlinzki D | Linhard VL | Merk D | Nilsson E | Saxena K | Schubert-Zsilavecz M | Schwalbe H | Sreeramulu S | Wissler L
